Tuesday, February 28, 2023 9:13:05 PM
I find this to be very interesting and super bullish for $RVVTF
Who can tell me why?
Whoever figures it out first, gets an Ataboy award.
https://www.pharmaceutical-technology.com/news/fda-fast-track-axcella-axa1125-nash/
Who can tell me why?
Whoever figures it out first, gets an Ataboy award.
https://www.pharmaceutical-technology.com/news/fda-fast-track-axcella-axa1125-nash/
Bullish
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
